Urticaria and comorbidities

Urticaria is a mast cell (MC)-driven skin disease. Degranulation of these cells is triggered by the activation of several receptors on its surface. The activation of MC in chronic spontaneous urticaria (CSU) appears to be associated with an autoimmune etiology. Certain comorbidities such as autoimmunity, infections, allergy, emotional stress, and metabolic syndrome are frequently associated with chronic urticaria (CU). The objective of this review is to highlight the frequent association between CU and several comorbidities, which can lead to a worse prognosis for the underlying disease. We searched for original and review articles on CU and comorbidities in PUBMED, abstracts published in AAAAI and EAACI; all of them in English. Our review reinforced how CSU, being itself an autoimmune disease, is strongly linked to several other autoimmune diseases. Besides autoimmunity, emotional stress was considered another frequent comorbidity associated with CU and also a trigger factor for urticaria exacerbation. Some studies recently considered CU as a low-grade chronic inflammatory condition and may be associated with metabolic syndrome. In conclusion, CU is considered a heterogeneous disease with distinct clinical features. It is worth remembering that CU should not be considered just a skin disease and its complete control could minimize a worse clinical outcome.

[1]  E. Zeydan,et al.  Identification of chronic urticaria subtypes using machine learning algorithms , 2021, Allergy.

[2]  M. Maurer,et al.  Autoimmune chronic spontaneous urticaria detection with IgG anti-TPO and total IgE. , 2021, The journal of allergy and clinical immunology. In practice.

[3]  Riddhi S. Parikh,et al.  Severe urticarial rash as the initial symptom of COVID-19 infection , 2021, BMJ Case Reports.

[4]  T. Jakob,et al.  Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria , 2021, Allergy, asthma & immunology research.

[5]  J. Kalil,et al.  Comorbidities in Patients with Chronic Urticaria , 2021 .

[6]  M. Maurer,et al.  Total IgE as a Marker for Chronic Spontaneous Urticaria , 2021, Allergy, asthma & immunology research.

[7]  T. Zuberbier,et al.  The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria , 2020, Allergy.

[8]  Kecheng Zhang,et al.  IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria , 2020, Allergy.

[9]  G. Canonica,et al.  Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology , 2020, Clinical and Molecular Allergy.

[10]  G. Konstantinou,et al.  Psychological stress and chronic urticaria: A neuro-immuno-cutaneous crosstalk. A systematic review of the existing evidence. , 2020, Clinical therapeutics.

[11]  K. Schäkel,et al.  Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020 , 2020, International Archives of Allergy and Immunology.

[12]  S. González-Díaz,et al.  Chronic urticaria and thyroid pathology , 2020, The World Allergy Organization journal.

[13]  L. Dumoutier,et al.  Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria. , 2020, European annals of allergy and clinical immunology.

[14]  C. Vestergaard,et al.  Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study , 2020, The World Allergy Organization journal.

[15]  J. Bartra,et al.  Progress in understanding hypersensitivity reactions to nonsteroidal anti‐inflammatory drugs , 2020, Allergy.

[16]  J. S. Lee,et al.  Systematic review and meta‐analysis: Effect of Helicobacter pylori eradication on chronic spontaneous urticaria , 2019, Helicobacter.

[17]  C. Bindslev‐Jensen,et al.  Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study , 2019, Allergy.

[18]  C. Grattan,et al.  Is chronic urticaria more than skin deep? , 2019, Clinical and Translational Allergy.

[19]  G. Konstantinou,et al.  Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis , 2019, Clinical and Translational Allergy.

[20]  N. Lomidze,et al.  ASSOCIATION BETWEEN URTICARIA AND INFECTIONS (REVIEW). , 2019, Georgian medical news.

[21]  T. S. Tat Higher Levels of Depression and Anxiety in Patients with Chronic Urticaria , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[22]  M. Romano,et al.  The overlap syndrome of urticaria and gastroesophageal reflux disease , 2018, PloS one.

[23]  T. Tsai,et al.  Association between sleep disorders and subsequent chronic spontaneous urticaria development , 2018, Medicine.

[24]  F. Sung,et al.  Associations of chronic urticaria with atopic and autoimmune comorbidities: a nationwide population‐based study , 2018, International journal of dermatology.

[25]  T. Zuberbier,et al.  The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria , 2018, Allergy.

[26]  M. Maurer,et al.  Comorbidity of viral hepatitis and chronic spontaneous urticaria: A systematic review , 2018, Allergy.

[27]  A. Zalewska-Janowska,et al.  Stress, itch and quality of life in chronic urticaria females , 2018, Postepy dermatologii i alergologii.

[28]  B. Panaszek,et al.  Eradication of Helicobacter pylori, as add-on therapy, has a significant, but temporary influence on recovery in chronic idiopathic urticaria: a placebo-controlled, double blind trial in the Polish population , 2018, Postepy dermatologii i alergologii.

[29]  S. Valitutti,et al.  New roles and controls of mast cells. , 2018, Current opinion in immunology.

[30]  D. Linder,et al.  Chronic urticaria and the metabolic syndrome: a cross‐sectional community‐based study of 11 261 patients , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[31]  O. Schmetzer,et al.  IL‐24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria , 2017, The Journal of allergy and clinical immunology.

[32]  Qiongyan Zhou,et al.  Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria , 2017, Scientific Reports.

[33]  D. Sasseville,et al.  Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria , 2017, JAMA dermatology.

[34]  M. Maurer,et al.  Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review. , 2017, Autoimmunity reviews.

[35]  M. Maurer,et al.  Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review , 2017, Allergy.

[36]  N. Agmon-Levin,et al.  Chronic urticaria and atopic disorders: a cross‐sectional study of 11 271 patients , 2017, The British journal of dermatology.

[37]  M. C. Castillo,et al.  Mast cell activation disease associated with autoimmune thyroid disease: case report and review of literature , 2017 .

[38]  G. Vena,et al.  The link between chronic spontaneous urticaria and metabolic syndrome. , 2017, European annals of allergy and clinical immunology.

[39]  H. Subramanian,et al.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. , 2016, The Journal of allergy and clinical immunology.

[40]  M. Maurer,et al.  Chronic spontaneous urticaria and internal parasites – a systematic review , 2016, Allergy.

[41]  M. Maurer,et al.  Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus – a systematic review , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  J. Wood,et al.  Mast Cell: A Multi-Functional Master Cell , 2016, Front. Immunol..

[43]  U. Gieler,et al.  Quality of Life and Comorbidities in Urticaria: What Is Known? , 2015, Current Dermatology Reports.

[44]  Guangjie Chen,et al.  Mast Cell and Autoimmune Diseases , 2015, Mediators of inflammation.

[45]  S. Gangemi,et al.  Urticaria and bacterial infections. , 2014, Allergy and asthma proceedings.

[46]  T. Zuberbier,et al.  Chronic urticaria as a systemic disease. , 2014, Clinics in dermatology.

[47]  Y. Ye,et al.  Co-existence of chronic urticaria and metabolic syndrome: clinical implications. , 2013, Acta dermato-venereologica.

[48]  P. Schmid‐Grendelmeier,et al.  EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria , 2013, Allergy.

[49]  A. Cummings,et al.  Mechanism of action of stinging nettles. , 2011, Wilderness & environmental medicine.

[50]  M. Boguniewicz The autoimmune nature of chronic urticaria. , 2008, Allergy and asthma proceedings.

[51]  A. Gasbarrini,et al.  Beneficial Effects of Helicobacter pylori Eradication on Idiopathic Chronic Urticaria , 1998, Digestive Diseases and Sciences.

[52]  I. Moneo,et al.  Anisakis simplex, a relevant etiologic factor in acute urticaria , 1997, Allergy.

[53]  A R Feinstein,et al.  THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE. , 1970, Journal of chronic diseases.